Guang Wu

Key Laboratory Of Laboratory Medicine
Wenzhou, 325035, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 22 publications

A novel therapeutic monoclonal antibody targeting PZR demonstrates potent anti-metastatic efficacy in triple-negative breast cancer.

A novel therapeutic monoclonal antibody targeting PZR demonstrates potent anti-metastatic efficacy in triple-negative breast cancer.

Journal: Journal of translational medicine

Published: December 28, 2025

Repurposing primaquine diphosphate for imatinib-resistant chronic myeloid leukemia via targeting BCR-ABL and Wnt/β-catenin pathway.

Repurposing primaquine diphosphate for imatinib-resistant chronic myeloid leukemia via targeting BCR-ABL and Wnt/β-catenin pathway.

Journal: iScience

Published: December 23, 2025

Gomisin G Inhibits Pancreatic Cancer Cell Growth by Promoting YAP Degradation.

Gomisin G Inhibits Pancreatic Cancer Cell Growth by Promoting YAP Degradation.

Journal: Food science & nutrition

Published: December 04, 2025

Zoledronic Acid Inhibits the Growth of ER-Positive Breast Cancer Cells by Inducing Ferroptosis.

Zoledronic Acid Inhibits the Growth of ER-Positive Breast Cancer Cells by Inducing Ferroptosis.

Journal: Biomolecules & therapeutics

Published: July 09, 2025

Comprehensive analysis identifies AMIGO2 as a potential prognosis biomarker of pancreatic adenocarcinoma.

Comprehensive analysis identifies AMIGO2 as a potential prognosis biomarker of pancreatic adenocarcinoma.

Journal: Journal of gastrointestinal oncology

Published: January 02, 2025

USP35 promotes the growth of ER positive breast cancer by inhibiting ferroptosis via BRD4-SLC7A11 axis.

USP35 promotes the growth of ER positive breast cancer by inhibiting ferroptosis via BRD4-SLC7A11 axis.

Journal: Communications biology

Published: June 15, 2024

Targeting estrogen-regulated system xc- promotes ferroptosis and endocrine sensitivity of ER+ breast cancer.

Targeting estrogen-regulated system xc- promotes ferroptosis and endocrine sensitivity of ER+ breast cancer.

Journal: Cell death & disease

Published: June 05, 2024

KCTD5 regulates Ikaros degradation induced by chemotherapeutic drug etoposide in hematological cells.

KCTD5 regulates Ikaros degradation induced by chemotherapeutic drug etoposide in hematological cells.

Journal: Biological chemistry

Published: October 24, 2023

PRRG4 regulates mitochondrial function and promotes migratory behaviors of breast cancer cells through the Src-STAT3-POLG axis.

PRRG4 regulates mitochondrial function and promotes migratory behaviors of breast cancer cells through the Src-STAT3-POLG axis.

Journal: Cancer cell international

Published: September 19, 2023

Zoledronic acid induces ferroptosis by reducing ubiquinone and promoting HMOX1 expression in osteosarcoma cells.

Zoledronic acid induces ferroptosis by reducing ubiquinone and promoting HMOX1 expression in osteosarcoma cells.

Journal: Frontiers in pharmacology

Published: October 17, 2022

Antitumor effect of a novel humanized MUC1 antibody-drug conjugate on triple-negative breast cancer.

Antitumor effect of a novel humanized MUC1 antibody-drug conjugate on triple-negative breast cancer.

Journal: Heliyon

Published: September 11, 2022

Vesicle-mediated transport-related genes are prognostic predictors and are associated with tumor immunity in lung adenocarcinoma.

Vesicle-mediated transport-related genes are prognostic predictors and are associated with tumor immunity in lung adenocarcinoma.

Journal: Frontiers in immunology

Published: September 02, 2022

Showing 1-12 of 22

Last Updated: 09/26/2026